RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MANDALà M
Collezione AOU Città della Salute di Torino

Items : 6

BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2023 Oct;37(10):1991-1998. doi: 10.1111/jdv.19281. Epub 2023 Jun 27.

2023
AOU Città della Salute di Torino

Pisano M; Roila F; de Giorgi V; Pimpinelli N; Romano L; Ribero S; Avallone G; Senetta R; Rubatto M; Osella Abate S; Gili A; Castiglione F; Marasciulo F; Baglivo S; Ludovini V; Palmieri G; Mandalà M; Casula M; Manca A; Sini MC; Massi D; Quaglino P;

Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Oct 18;158:156-168. doi: 10.1016/j.ejca.2021.09.023.

2021
AOU Città della Salute di Torino

Eggermont AM; Meshcheryakov A; Atkinson V; Blank CU; Mandala M; Long GV; Barrow C; Di Giacomo AM; Fisher R; Sandhu S; Kudchadkar R; Ortiz Romero PL; Svane IM; Larkin J; Puig S; Hersey P; Quaglino P; Queirolo P; Stroyakovskiy D; Bastholt L; Mohr P; Hernberg M; Chiarion-Sileni V; Strother M; Hauschild A; Yamazaki N; van Akkooi AC; Lorigan P; Krepler C; et alii...

Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI). in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Sep;137:30-39. doi: 10.1016/j.ejca.2020.07.001. Epub 2020 Jul 30.

2020
AOU Città della Salute di Torino

Mandalà M; Galli F; Patuzzo R; Maurichi A; Mocellin S; Rossi CR; Rulli E; Montesco M; Quaglino P; Caliendo V; De Giorgi V; Merelli B; Caracò C; Piazzalunga D; Labianca A; Ribero S; Senetta R; Gianatti A; Valeri B; Massi D; Ascierto PA; Santinami M; Mandalà M; Galli F; Patuzzo R; Maurichi A; Mocellin S; Rossi CR; Rulli E; et alii...

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy. in Cancers / Cancers (Basel). 2020 Oct 26;12(11):3131. doi: 10.3390/cancers12113131.

2020
AOU Città della Salute di Torino

Teterycz P; Czarnecka AM; Indini A; Spa?ek MJ; Labianca A; Rogala P; Cybulska-Stopa B; Quaglino P; Ricardi U; Badellino S; Szumera-Cie?kiewicz A; Falkowski S; Mandala M; Rutkowski P;

Corrigendum to "Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)" [Eur J Canc 137 (2020). Pages 30-39]. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Nov;139:204-205. doi: 10.1016/j.ejca.2020.09.002. Epub 2020 Sep 23.

2020
AOU Città della Salute di Torino

Valeri B; Gianatti A; Senetta R; Ribero S; Labianca A; Piazzalunga D; Caracò C; Merelli B; De Giorgi V; Caliendo V; Quaglino P; Montesco M; Rossi CR; Rulli E; Mocellin S; Maurichi A; Patuzzo R; Galli F; Mandalà M; Massi D; Ascierto PA; Santinami M;

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. in Journal of translational medicine / J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2.

2016
AOU Città della Salute di Torino

Nanda VGY; Peng W; Hwu P; Davies MA; Ciliberto G; Fattore L; Malpicci D; Aurisicchio L; Ascierto PA; Croce CM; Mancini R; Spranger S; Gajewski TF; Wang Y; Ferrone S; Vanpouille-Box C; Wennerberg E; Pilones KA; Formenti SC; Demaria S; Tang H; Wang Y; Fu YX; Dummer R; Puzanov I; Tarhini A; Chauvin JM; Pagliano O; Fourcade J; et alii...